-
La Puma J. Vitamin A and fracture risk. Altern Med Alert 2003;6(3):36.
-
This article reviews multiple aspects of heart failure, providing direction for workup and management of heart failure patients. All recommendations follow current published guidelines. Unresolved and controversial issues are reviewed, and future therapies are proposed.
-
FDA Issues Black Box Warning Based on WHI Study; ALLHAT: Thiazide for Hypertension Treatment; Candesartan Effective Against Migraines; Cough! No Cold Relief from Echinacea; COX-2 Inhibitors and GI Benefits Could Be Overrated; FDA Actions;
-
-
Synopsis: Sirolimus-eluting stents markedly reduce in-stent restenosis and clinical events over 1 year in patients with restenosis in conventional stents.
-
-
There has been a drum roll of reports over the past several years regarding high-sensitivity c-reactive protein (hs-CRP) in the evaluation of primary and secondary cardiovascular prevention.
-
Synopsis: In asymptomatic patients with preexcitation, electrophysiologic testing can stratify the risk of future symptomatic and fatal arrhythmic events.
-
Synopsis: Amiodarone is superior to placebo for cardioversion of AF when measured at 24 hours after drug administration.
-
Synopsis: Death due to cardiac structural complications is rare in young Marfans patients followed carefully on medical therapy, but arrhythmogenic sudden death occurs and is more common in those with LV dilatation.
